Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cedirogant (ABBV-157) is an orally active retinoid-related orphan receptor-γt(RORγt) inverse agonist that is used for psoriasis study.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 29,500 | |||
5 mg | 在庫あり | ¥ 62,500 | |||
10 mg | 在庫あり | ¥ 99,500 | |||
25 mg | 在庫あり | ¥ 166,000 | |||
50 mg | 在庫あり | ¥ 226,500 | |||
100 mg | 在庫あり | ¥ 317,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 75,500 |
説明 | Cedirogant (ABBV-157) is an orally active retinoid-related orphan receptor-γt(RORγt) inverse agonist that is used for psoriasis study. |
別名 | ABBV-157 |
分子量 | 547.78 |
分子式 | C24H20Cl3F3N2O3 |
CAS No. | 2055496-11-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200 mg/mL(365.11 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cedirogant 2055496-11-0 Metabolism ROR Inhibitor inverse RORγt ABBV 157 RAR-related orphan receptor psoriasis ABBV-157 inhibit agonist ABBV157 inhibitor